News | February 24, 2021
USFDA denies Sun Pharma Advanced Research’s appeal of NDA for Taclantis
The company will review FDA's response and decide on appropriate next steps soon.
The company will review FDA's response and decide on appropriate next steps soon.
Subscribe To Our Newsletter & Stay Updated